| Erick A Salvatierra, MD | |
|
439 Heymann Blvd, Lafayette, LA 70503-2616 | |
| (337) 269-0963 | |
| (337) 269-0553 |
| Full Name | Erick A Salvatierra |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Experience | 20 Years |
| Location | 439 Heymann Blvd, Lafayette, Louisiana |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1508067653 | NPI | - | NPPES |
| 1067024 | Medicaid | LA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RG0100X | Internal Medicine - Gastroenterology | 200354 (Louisiana) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Lafayette General Medical Center | Lafayette, LA | Hospital |
| Our Lady Of Lourdes Regional Medical Center, Inc | Lafayette, LA | Hospital |
| Opelousas General Health System | Opelousas, LA | Hospital |
| Acadia General Hospital | Crowley, LA | Hospital |
| Iberia Medical Center | New iberia, LA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Louisiana Gastroenterology Associates Llc | 4789079781 | 23 |
News Archive
ORBIS Canada, a non-profit global development organization dedicated to saving sight worldwide, is launching a series of holiday cards available for purchase this season. Proceeds of these cards will be used to build ORBIS Kids Sight treatment centres in the developing world.
Salix Pharmaceuticals and Pharming Group NV announced today that the U.S. Food and Drug Administration has granted 12 years of exclusivity to RUCONEST (C1 esterase inhibitor [recombinant]) 50 IU/kg.
According to a team of Israeli scientists the faces we pull when we are emotional are inherited from our ancestors.
University of Utah Department of Medicine researchers have received $16 million from the National Institutes of Health (NIH) to set up a translational research center to study the cellular and molecular causes of blood clots, a serious threat to millions of people who have diabetes, are obese or have other metabolic disorders.
Given that 10.5 % of patients who receive a transplant reject the new organ, researchers at the Center of Research and Advanced Studies of the National Polytechnic Institute (Cinvestav) are working in the design of a tool capable of preventing this problem.
› Verified 8 days ago
| Entity Name | Acadiana Gastroenterology Associates, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1285963934 PECOS PAC ID: 6204964810 Enrollment ID: O20100503000036 |
News Archive
ORBIS Canada, a non-profit global development organization dedicated to saving sight worldwide, is launching a series of holiday cards available for purchase this season. Proceeds of these cards will be used to build ORBIS Kids Sight treatment centres in the developing world.
Salix Pharmaceuticals and Pharming Group NV announced today that the U.S. Food and Drug Administration has granted 12 years of exclusivity to RUCONEST (C1 esterase inhibitor [recombinant]) 50 IU/kg.
According to a team of Israeli scientists the faces we pull when we are emotional are inherited from our ancestors.
University of Utah Department of Medicine researchers have received $16 million from the National Institutes of Health (NIH) to set up a translational research center to study the cellular and molecular causes of blood clots, a serious threat to millions of people who have diabetes, are obese or have other metabolic disorders.
Given that 10.5 % of patients who receive a transplant reject the new organ, researchers at the Center of Research and Advanced Studies of the National Polytechnic Institute (Cinvestav) are working in the design of a tool capable of preventing this problem.
› Verified 8 days ago
| Entity Name | University Hospital & Clinics, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1639518087 PECOS PAC ID: 7113161977 Enrollment ID: O20130917000335 |
News Archive
ORBIS Canada, a non-profit global development organization dedicated to saving sight worldwide, is launching a series of holiday cards available for purchase this season. Proceeds of these cards will be used to build ORBIS Kids Sight treatment centres in the developing world.
Salix Pharmaceuticals and Pharming Group NV announced today that the U.S. Food and Drug Administration has granted 12 years of exclusivity to RUCONEST (C1 esterase inhibitor [recombinant]) 50 IU/kg.
According to a team of Israeli scientists the faces we pull when we are emotional are inherited from our ancestors.
University of Utah Department of Medicine researchers have received $16 million from the National Institutes of Health (NIH) to set up a translational research center to study the cellular and molecular causes of blood clots, a serious threat to millions of people who have diabetes, are obese or have other metabolic disorders.
Given that 10.5 % of patients who receive a transplant reject the new organ, researchers at the Center of Research and Advanced Studies of the National Polytechnic Institute (Cinvestav) are working in the design of a tool capable of preventing this problem.
› Verified 8 days ago
| Entity Name | Louisiana Gastroenterology Associates Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1366195091 PECOS PAC ID: 4789079781 Enrollment ID: O20220309001421 |
News Archive
ORBIS Canada, a non-profit global development organization dedicated to saving sight worldwide, is launching a series of holiday cards available for purchase this season. Proceeds of these cards will be used to build ORBIS Kids Sight treatment centres in the developing world.
Salix Pharmaceuticals and Pharming Group NV announced today that the U.S. Food and Drug Administration has granted 12 years of exclusivity to RUCONEST (C1 esterase inhibitor [recombinant]) 50 IU/kg.
According to a team of Israeli scientists the faces we pull when we are emotional are inherited from our ancestors.
University of Utah Department of Medicine researchers have received $16 million from the National Institutes of Health (NIH) to set up a translational research center to study the cellular and molecular causes of blood clots, a serious threat to millions of people who have diabetes, are obese or have other metabolic disorders.
Given that 10.5 % of patients who receive a transplant reject the new organ, researchers at the Center of Research and Advanced Studies of the National Polytechnic Institute (Cinvestav) are working in the design of a tool capable of preventing this problem.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Erick A Salvatierra, MD 439 Heymann Blvd, Lafayette, LA 70503-2616 Ph: (337) 269-0963 | Erick A Salvatierra, MD 439 Heymann Blvd, Lafayette, LA 70503-2616 Ph: (337) 269-0963 |
News Archive
ORBIS Canada, a non-profit global development organization dedicated to saving sight worldwide, is launching a series of holiday cards available for purchase this season. Proceeds of these cards will be used to build ORBIS Kids Sight treatment centres in the developing world.
Salix Pharmaceuticals and Pharming Group NV announced today that the U.S. Food and Drug Administration has granted 12 years of exclusivity to RUCONEST (C1 esterase inhibitor [recombinant]) 50 IU/kg.
According to a team of Israeli scientists the faces we pull when we are emotional are inherited from our ancestors.
University of Utah Department of Medicine researchers have received $16 million from the National Institutes of Health (NIH) to set up a translational research center to study the cellular and molecular causes of blood clots, a serious threat to millions of people who have diabetes, are obese or have other metabolic disorders.
Given that 10.5 % of patients who receive a transplant reject the new organ, researchers at the Center of Research and Advanced Studies of the National Polytechnic Institute (Cinvestav) are working in the design of a tool capable of preventing this problem.
› Verified 8 days ago
Dr. Maximo Bienvenido Lamarche, M.D. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 300 W Saint Mary Blvd, Lafayette, LA 70506 Phone: 337-233-6593 Fax: 337-235-1032 | |
Dr. John M Rainey, M.D. Gastroenterology Medicare: Medicare Enrolled Practice Location: 501 W Saint Mary Blvd, Lafayette, LA 70506 Phone: 337-235-7898 Fax: 337-235-7445 | |
Dr. Corwin Ashford Thomas, D.O. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 802 E Farrel Rd, Lafayette, LA 70508 Phone: 337-234-3163 Fax: 337-234-3168 | |
Dr. Matthew Shane Fontenot, M.D. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 1214 Coolidge Blvd, Lafayette, LA 70503 Phone: 337-289-7927 Fax: 337-289-7935 | |
Dr. John Brent Rhodes Jr., M.D. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 439 Heymann Blvd, Lafayette, LA 70503 Phone: 337-269-0963 Fax: 337-269-0553 | |
Leela P. Lakshmiprasad, MD Gastroenterology Medicare: Not Enrolled in Medicare Practice Location: Lsu Medicine Clinic, 2390 W Congress Street, Lafayette, LA 70506 Phone: 337-261-6100 | |
Dr. Kamalendra Nath Mondal, MD Gastroenterology Medicare: Medicare Enrolled Practice Location: 3149 Ambassador Caffery Pkwy, Lafayette, LA 70506 Phone: 337-706-3415 |